✨ Health Notices
2092
NEW ZEALAND GAZETTE
No. 86
Pursuant to clause 2(1) of the Second Schedule to the Health and Disability Services Act 1993, I appoint Ian Miller as Chairperson of the Board of the Residual Health Management Unit, commencing on the date of appointment and expiring on the 30th day of June 2001.
Director
Ian Miller
From the date of appointment until 30 June 2001.
Peter Farley
From the date of appointment until 30 June 2001.
Peter Kemp
From the date of appointment until 30 June 2001.
Schedule
Compliance with the Management Agreement dated 30 September 1993 between the Minister of Health and the Residual Health Management Unit.
Dated at Wellington this 2nd day of August 2000.
ANNETTE KING, Minister of Health.
go5712
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Hytacand
Active Ingredient(s): Candesartan cilexetil 8mg
Hydrochlorothiazide 12.5mg
Dosage Form: Tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Gartunavagen, Sodertalje, Sweden
Product: Teveten
Active Ingredient(s): Eprosartan mesylate 735.8mg equivalent to 600mg eprosartan
Dosage Form: Film coated tablet
New Zealand Sponsor: Russells Pharmaceuticals Limited
Manufacturer(s): SmithKline Beecham Pharmaceuticals Co, Bario Certenejas, Cidra, Puerto Rico
SmithKline Beecham Pharmaceuticals Limited, Magpie Wood, Manor Royal, Crawley, Sussex, England
Dated this 26th day of July 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go5571
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24(5) of the act and are set out in the Schedule hereto:
Schedule
Product: Ultiva
Active Ingredient(s): Remifentanil hydrochloride 1.1mg equivalent to 1mg remifentanil
Dosage Form: Powder for injection
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Pharmacia & Upjohn NV/SA, Puurs, Belgium
Product: Ultiva
Active Ingredient(s): Remifentanil hydrochloride 2.2mg equivalent to 2mg remifentanil
Dosage Form: Powder for injection
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Pharmacia & Upjohn NV/SA, Puurs, Belgium
Product: Ultiva
Active Ingredient(s): Remifentanil hydrochloride 5.5mg equivalent to 5mg remifentanil
Dosage Form: Powder for injection
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Pharmacia & Upjohn NV/SA, Puurs, Belgium
Dated this 26th day of July 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go5570
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 86
Gazette.govt.nz —
NZ Gazette 2000, No 86
✨ LLM interpretation of page content
🏥 Appointment of Chairperson of Residual Health Management Unit
🏥 Health & Social Welfare2 August 2000
Health and Disability Services Act 1993, Residual Health Management Unit, Chairperson Appointment
- Ian Miller, Appointed Chairperson of Residual Health Management Unit
- Peter Farley, Appointed Director of Residual Health Management Unit
- Peter Kemp, Appointed Director of Residual Health Management Unit
- Aninette King, Minister of Health
🏥 Consent to Distribution of New Medicine - Hytacand and Teveten
🏥 Health & Social Welfare26 July 2000
Medicines Act 1981, New Medicine, Hytacand, Teveten, Candesartan cilexetil, Hydrochlorothiazide, Eprosartan mesylate
- G. R. Boyd, Chief Advisor, Safety and Regulation
🏥 Consent to Distribution of Changed Medicines - Ultiva
🏥 Health & Social Welfare26 July 2000
Medicines Act 1981, Changed Medicine, Ultiva, Remifentanil hydrochloride
- G. R. Boyd, Chief Advisor, Safety and Regulation